Cargando…
Antineutrophil Cytoplasmic Autoantibody–Associated Glomerulonephritis Following the Pfizer-BioNTech COVID-19 Vaccine
Autores principales: | Dube, Geoffrey K., Benvenuto, Luke J., Batal, Ibrahim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372490/ https://www.ncbi.nlm.nih.gov/pubmed/34423176 http://dx.doi.org/10.1016/j.ekir.2021.08.012 |
Ejemplares similares
-
COVID-19-Vaccine-Pfizer-BioNTech: Antineutrophil cytoplasmic autoantibody and pauci-immune crescentic glomerulonephritis: case report
Publicado: (2022) -
Antineutrophil Cytoplasmic Antibody-associated Vasculitis after COVID-19 Vaccination with Pfizer-BioNTech
por: Suzuki, Minami, et al.
Publicado: (2022) -
Antineutrophil Cytoplasmic Antibody and Multiple Sclerosis
por: George, Jason C., et al.
Publicado: (2017) -
Antineutrophil Cytoplasmic Autoantibody-Associated Glomerulonephritis as a Possible Side Effect of COVID-19 Vaccination
por: Noel, Edva, et al.
Publicado: (2022) -
Treatment of Aggressive Antineutrophil Cytoplasmic Antibody–Associated Vasculitis With Eculizumab
por: Huizenga, Noah, et al.
Publicado: (2019)